Status:

COMPLETED

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Lead Sponsor:

Burapha University

Conditions:

Sepsis and Septic Shock

Eligibility:

All Genders

18+ years

Brief Summary

This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult pat...

Eligibility Criteria

Inclusion

  • aged 18 years or older
  • diagnosed with sepsis or septic shock according to Sepsis-3 criteria
  • received an echocardiogram within 72 hours after admission

Exclusion

  • prior diagnosis of pulmonary hypertension,
  • cor-pulmonale,
  • significant valvular heart disease,
  • acute coronary syndrome,
  • aortic dissection,
  • heart failure
  • inability to follow up within 28 days

Key Trial Info

Start Date :

October 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06193109

Start Date

October 1 2022

End Date

July 30 2023

Last Update

January 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Burapha University Hospital

Muang Chonburi, Changwat Chon Buri, Thailand, 20131